These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 9700980

  • 1. Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
    Li P, Ferrario CM, Brosnihan KB.
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):198-205. PubMed ID: 9700980
    [Abstract] [Full Text] [Related]

  • 2. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 3. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries.
    Li P, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1065-70. PubMed ID: 9190837
    [Abstract] [Full Text] [Related]

  • 4. Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide.
    Maeso R, Rodrigo E, Muñoz-Garcia R, Navarro-Cid J, Ruilope LM, Lahera V, Cachofeiro V.
    J Hypertens; 1997 Dec; 15(12 Pt 2):1677-84. PubMed ID: 9488222
    [Abstract] [Full Text] [Related]

  • 5. Effects of losartan on contractile responses of conductance and resistance arteries from rats.
    Corriu C, Bernard S, Schott C, Stoclet JC.
    J Cardiovasc Pharmacol; 1995 Nov; 26(5):688-92. PubMed ID: 8637181
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II AT(1) receptor antagonists and platelet activation.
    López-Farré A, Sánchez de Miguel L, Montón M, Jiménez A, Lopez-Bloya A, Gómez J, Núñez A, Rico L, Casado S.
    Nephrol Dial Transplant; 2001 Nov; 16 Suppl 1():45-9. PubMed ID: 11369820
    [Abstract] [Full Text] [Related]

  • 7. The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo.
    Fukuhara M, Neves LA, Li P, Diz DI, Ferrario CM, Brosnihan KB.
    J Hypertens; 2001 Mar; 19(3 Pt 2):561-6. PubMed ID: 11327630
    [Abstract] [Full Text] [Related]

  • 8. [Effect of losartan on human platelet activation by thromboxane A2].
    Guerra JI, Montón M, Rodríguez-Feo JA, Farré J, Jiménez AM, Núñez A, Gómez J, Rico L, Marcos P, Castilla C, Sánchez De Miguel L, Casado S, López-Farré A.
    Rev Esp Cardiol; 2000 Apr; 53(4):525-30. PubMed ID: 10758030
    [Abstract] [Full Text] [Related]

  • 9. Antagonistic effects of losartan on thromboxane A2-receptors in human isolated gastroepiploic artery and saphenous vein.
    Tripodi F, Stanke-Labesque F, Devillier P, Chavanon O, Sessa C, Bessard G.
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):734-40. PubMed ID: 10547091
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Montón M, Jiménez A, Núñez A, López-Blaya A, Farré J, Gómez J, Zalba LR, Sánchez de Miguel L, Casado S, López-Farré A.
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):906-13. PubMed ID: 10836725
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
    Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T.
    Hypertension; 2002 Oct; 40(4):521-7. PubMed ID: 12364357
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
    Nossaman BD, Baber SR, Nazim MM, Detrolio JD, Kadowitz PJ.
    Can J Physiol Pharmacol; 2007 Oct; 85(3-4):360-71. PubMed ID: 17612645
    [Abstract] [Full Text] [Related]

  • 13. Effect of losartan on human platelet activation.
    Guerra-Cuesta JI, Montón M, Rodríguez-Feo JA, Jiménez AM, González-Fernández F, Rico LA, García R, Gómez J, Farré J, Casado S, López-Farré A.
    J Hypertens; 1999 Mar; 17(3):447-52. PubMed ID: 10100084
    [Abstract] [Full Text] [Related]

  • 14. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin.
    Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M.
    Br J Pharmacol; 2005 Nov; 146(6):834-45. PubMed ID: 16158068
    [Abstract] [Full Text] [Related]

  • 15. [Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog].
    Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW.
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):971-4. PubMed ID: 7755474
    [Abstract] [Full Text] [Related]

  • 16. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 17. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
    Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.
    Schwemmer M, Sommer O, Bassenge E.
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):301-7. PubMed ID: 11800413
    [Abstract] [Full Text] [Related]

  • 19. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E, Maeso R, Muñoz-García R, Navarro-Cid J, Ruilope LM, Cachofeiro V, Lahera V.
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [Abstract] [Full Text] [Related]

  • 20. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
    Maeso R, Navarro-Cid J, Muñoz-García R, Rodrigo E, Ruilope LM, Lahera V, Cachofeiro V.
    Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.